Portfolio Advancing Portfolio Screening Program RFP Year2020 Awarded Amount $122,013 DiseaseMalaria InterventionDrug Development Stage Hit Identification Collaboration Partners Daiichi Sankyo, Inc., Medicines for Malaria Venture (MMV)